back to sign in
tākt

Medical and Wellness Disclaimer

Effective date: June 10, 2026 Last updated: June 10, 2026

1.1 Read this before using Tākt

Tākt is a tracking and educational tool. It is not intended to be a medical service, a medical device, or a substitute for professional medical advice, diagnosis, or treatment. The information, calculators, reference content, and educational notices in Tākt are general in nature. They are not personalized medical advice and they are not a recommendation to take, dose, combine, or stop any compound, supplement, peptide, or medication.

You should always consult a qualified healthcare professional who knows your full medical history before starting, changing, or stopping any supplement, peptide, medication, or wellness practice. Never disregard professional medical advice or delay seeking it because of something you read or saw in Tākt.

If you think you are having a medical emergency, call 911 (or your local emergency number). If you are in mental health crisis or having thoughts of suicide or self-harm:

  • In Canada and the US, call or text 988 (Suicide Crisis Helpline)
  • In the UK, call 111, option 2, or Samaritans at 116 123
  • In the EU, call 112 for emergencies or your local crisis line

1.2 What Tākt is for

Tākt is intended to help you:

  • Keep a personal record of supplements, peptides, and other compounds you choose to track
  • Organize your protocols, schedules, and injection site rotation
  • Log goals and personal metrics so you can review them over time
  • Reference general educational information about compounds you are tracking
  • Use general-purpose calculators (for example, reconstitution math) on inputs you provide

These features support general wellness and personal tracking. They do not diagnose, treat, cure, mitigate, or prevent any disease or condition.

1.3 What Tākt is not

Tākt is not intended to be, and is not marketed as:

  • A medical professional or a substitute for one
  • A licensed pharmacy, prescriber, dispenser, or compounder
  • A telemedicine service
  • A diagnostic tool
  • A treatment plan
  • A clinical decision support system
  • An emergency service

Tākt does not prescribe, recommend, or supply any compound. The presence of a compound in our reference library is not an endorsement and not a recommendation that you take it, that it is safe for you, or that it is legal where you live.

1.4 You are the user, for yourself

Tākt is for personal use only. It is not designed or licensed for healthcare professionals to use in patient care, for compounders to use in operations, for coaches to use with clients, or for anyone to log compounds on someone else's behalf. The data you log, the calculations you perform, and the decisions you make are about your own protocol.

1.5 Compounds with special regulatory status

Some compounds users track in Tākt (including peptides, research chemicals, and compounded medications) have varying legal and regulatory status across jurisdictions. Some are approved prescription medications in some countries and not in others. Some are sold as research chemicals not for human use. Some are sold as dietary supplements with limited regulatory oversight. Some are unapproved drugs that cannot be lawfully sold for human consumption in your country.

You are solely responsible for:

  • Knowing whether a compound is legal to possess and use where you live
  • Sourcing any compound lawfully and from a reputable source
  • Verifying the identity, purity, concentration, and sterility of what you obtain
  • Following the directions of a qualified healthcare professional if you choose to use it
  • Complying with any prescription or import requirement that applies to you

Tākt does not verify the source, identity, purity, concentration, sterility, or legality of any compound you log. Adverse events with unapproved or counterfeit compounds, including dosing errors and contamination, have been documented and reported.

1.6 GLP-1 receptor agonists and compounded versions

Some users of Tākt track GLP-1 receptor agonists, including the FDA-approved branded products (for example, Ozempic, Wegovy, Mounjaro, Zepbound) and compounded preparations of semaglutide and tirzepatide.

These medications have known risks, including but not limited to gastrointestinal effects, dehydration, gallbladder events, pancreatitis, hypoglycemia (especially in combination with insulin or sulfonylureas), thyroid C-cell tumors observed in animal studies, and effects during pregnancy and breastfeeding. They are not appropriate for everyone.

Important regulatory context, current as of June 10, 2026 and subject to change. The FDA removed both tirzepatide (October 2024) and semaglutide (February 2025) from its drug shortage list. Enforcement discretion for compounding ended in early 2025 (tirzepatide: February 18 / March 19, 2025; semaglutide: April 22 / May 22, 2025). Outside the narrow exceptions that allow lawful compounding (including a prescriber-documented clinically significant difference for an individual patient), 503A pharmacies and 503B outsourcing facilities are no longer permitted to compound copies of these drugs in the United States. Counterfeit and grey-market versions of these compounds remain widely available online and have been associated with documented dosing errors, contamination, and adverse events. Manufacturers (Eli Lilly and Novo Nordisk) have also pursued legal action against telehealth companies, wellness centers, and clinics offering compounded versions. As of April 30, 2026, the FDA has proposed removing semaglutide, tirzepatide, and liraglutide from the 503B bulks list, citing no clinical need for outsourcing-facility compounding from bulk substances; if finalized this would further restrict large-scale compounding.

If you are tracking a compounded GLP-1, that is a personal decision between you and your prescriber. Tākt does not certify the legality of what you are taking, does not validate the source, and does not endorse compounded products.

Only your prescribing clinician can determine whether any GLP-1 medication is appropriate for you, what dose to use, how to titrate it, what to monitor, and when to stop. Tākt does not make any of those determinations. Logging a medication in Tākt is a personal recordkeeping action, not a medical decision.

1.7 Reconstitution and dose calculators

Tākt provides calculators that perform arithmetic on inputs you provide (for example, vial size, BAC water volume, target dose, syringe units). These calculators are educational tools that compute the result of the math you have set up. They:

  • Do not verify the strength, purity, identity, or sterility of any product
  • Do not recommend a target dose
  • Do not account for your individual medical situation
  • Cannot detect or prevent a dosing error
  • Are only as accurate as the inputs you provide

Always verify any calculation with a qualified healthcare professional or pharmacist before drawing or administering any substance. If a calculator output and your prescriber's instructions disagree, follow your prescriber. If you are unsure, do not draw or administer.

When you first use a reconstitution calculator and at intervals thereafter, Tākt will ask you to confirm that you understand this and will independently verify before drawing.

1.8 Interaction information

Tākt may surface educational notices when two or more compounds you log have a documented interaction. These notices are general reference information drawn from public sources and may be incomplete, out of date, or not applicable to your specific situation.

The absence of an interaction notice in Tākt does not mean the combination is safe. The presence of an interaction notice in Tākt does not mean the combination will harm you.

Always discuss your full stack, including over-the-counter products, prescription medications, and any peptides, with a qualified healthcare professional and a pharmacist.

1.9 Side-effect logging and symptom tracking

If you log symptoms or side effects, Tākt provides a place to keep a record. Tākt does not diagnose your symptoms, does not characterize your data as normal or abnormal, and does not recommend any course of action.

Some side effects are urgent. Seek immediate medical attention for:

  • Severe or persistent abdominal pain (possible pancreatitis or gallbladder event with GLP-1s)
  • Signs of severe allergic reaction (swelling, difficulty breathing, hives)
  • Severe dehydration, persistent vomiting, or inability to keep fluids down
  • Signs of hypoglycemia (confusion, sweating, fainting, especially if you also use insulin or a sulfonylurea)
  • Signs of injection site infection (spreading redness, fever, severe pain, pus)
  • Any symptom that worries you, especially if it is new, severe, or worsening

If you experience symptoms that worry you, contact your healthcare provider. If it is an emergency, call 911.

1.10 Pregnancy, breastfeeding, fertility, and reproductive health

Many compounds are not safe during pregnancy or breastfeeding, may affect fertility, or may interact with reproductive hormones in ways that are not fully studied.

  • GLP-1 receptor agonists are generally not recommended during pregnancy. Manufacturers advise discontinuation at least two months (semaglutide) or four weeks (tirzepatide) before a planned pregnancy. There have been reports of "Ozempic babies" (unintended pregnancies in users who experienced restored fertility), so birth control precautions matter even if you have not been able to conceive previously. Talk to your prescriber.
  • Many peptides and research compounds have no human safety data in pregnancy, lactation, or fertility. The default assumption is to discontinue and consult your provider.
  • Hormonal compounds, anti-androgens, retinoids, and many supplements can affect fertility, pregnancy, and breastfeeding.
  • Perimenopause, menopause, PCOS, endometriosis, thyroid conditions, and other endocrine conditions affect how your body responds to many compounds. None of the educational content in Tākt is tailored to your specific condition.

If you are pregnant, planning a pregnancy, breastfeeding, trying to conceive, in perimenopause or menopause, or have any reproductive or endocrine condition, talk to your healthcare provider before using or continuing any compound.

1.11 Eating, exercise, body composition, and disordered eating

Goals, metrics, and trends in Tākt are personal recordkeeping. They are not a clinical assessment of your health, weight, or body composition.

If you have a current or past history of disordered eating, an eating disorder, exercise compulsion, or body dysmorphia, please be thoughtful about whether tracking is right for you. The same logging that some users find clarifying can be reinforcing in unhelpful ways for others. We strongly encourage you to work with a qualified clinician and to use Tākt under their guidance, or not at all, depending on what is best for you.

If you are in distress and need support:

  • National Eating Disorders Information Centre (NEDIC), Canada: nedic.ca, 1-866-633-4220
  • National Alliance for Eating Disorders, US: allianceforeatingdisorders.com, 1-866-662-1235
  • Beat, UK: beateatingdisorders.org.uk

1.12 No doctor-patient relationship

Use of Tākt does not create a doctor-patient relationship between you and Clique Agency Inc., its staff, or anyone associated with the Service. We are not your healthcare provider.

1.13 No reliance

You agree not to rely on Tākt as your sole source of information about any compound, dose, schedule, interaction, or medical question. Always cross-reference with your healthcare provider, pharmacist, and authoritative sources such as your country's drug regulator and reputable peer-reviewed literature.

1.14 Acceptance

By using Tākt you acknowledge that you have read, understood, and agreed to this Disclaimer. If you do not agree, do not use the Service. This Disclaimer is incorporated into and governed by the Terms of Service.